Skip to main content
logo
LakeShore Biopharma Co., Ltd (LSBCF)
OTCMKTS · Delayed Price · Currency is USD
0.8416
+0.0157 (1.90%)
Nov 19, 2025, 4:00 PM EST

LakeShore Biopharma Revenue

In the fiscal year ending March 31, 2025, LakeShore Biopharma had annual revenue of 614.96M CNY with 7.24% growth. LakeShore Biopharma had revenue of 135.35M in the quarter ending March 31, 2024, with 27.67% growth.

Revenue
614.96M CNY
Revenue Growth
-6.54%
P/S Ratio
0.41
Revenue / Employee
1.07M CNY
Employees
573
Market Cap
34.68M USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025614.96M41.54M7.24%
Mar 31, 2024573.42M-113.78M-16.56%
Mar 31, 2023687.20M184.25M36.63%
Mar 31, 2022502.95M245.93M95.69%
Mar 31, 2021257.02M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
American Oncology Network1.76B
Veradigm588.02M
Glass House Brands196.17M
Global Cord Blood196.10M
Elite Pharmaceuticals122.89M
Mid-Atlantic Home Health Network27.00M
Silence Therapeutics25.83M
Nuo Therapeutics2.61M
Revenue Rankings

LakeShore Biopharma News

More News